MTB
65
4
LEN
17
-6
MNST
57
-2
BBY
40
4
MDLZ
32
8
FAST
42
-2
AMP
46
3
HPE
35
2
KLAC
57
-5
FCX
49
-4
EXC
53
3
K
44
6
CMI
42
4
LUV
56
4
GLW
53
-2
AAPL
42
3
KEY
53
12
PYPL
60
4
FITB
59
3
FIS
58
-2
MTB
65
4
LEN
17
-6
MNST
57
-2
BBY
40
4
MDLZ
32
8
FAST
42
-2
AMP
46
3
HPE
35
2
KLAC
57
-5
FCX
49
-4
EXC
53
3
K
44
6
CMI
42
4
LUV
56
4
GLW
53
-2
AAPL
42
3
KEY
53
12
PYPL
60
4
FITB
59
3
FIS
58
-2
Financhill
Back

Blackbaud Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
51

BLKB
Blackbaud

Last Price:
$61.53
Seasonality Move:
4.54%
Buy
63

HALO
Halozyme Therapeutics

Last Price:
$52.82
Seasonality Move:
5.34%
Buy
51
Blackbaud (BLKB) is a Buy

Is Blackbaud a Buy, Sell or Hold?

  • The current Blackbaud [BLKB] share price is $61.50. The Score for BLKB is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • BLKB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $52.81. The Score for HALO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BLKB Stock Price Chart

What is Blackbaud's stock price today?

  • The Blackbaud share price today is $61.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLKB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $52.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BLKB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 47.03 Sell
Chaikin Money Flow: 608996 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.18 - 63.56) Sell
Bollinger Bands (100): (59.7 - 71.44) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 41.21 Sell
Chaikin Money Flow: -3919681 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.47 - 55.03) Sell
Bollinger Bands (100): (54.25 - 62.43) Sell

BLKB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.46 Buy
20-day SMA: 62.07 Sell
50-day SMA: 62.36 Sell
200-day SMA: 73.43 Sell
8-day EMA: 61.43 Buy
20-day EMA: 62.01 Sell
50-day EMA: 62.98 Sell
200-day EMA: 69.78 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.64 Sell
20-day SMA: 54.1 Sell
50-day SMA: 56.97 Sell
200-day SMA: 55.96 Sell
8-day EMA: 53.51 Sell
20-day EMA: 54.29 Sell
50-day EMA: 56.08 Sell
200-day EMA: 55.12 Sell

Blackbaud Earnings Growth & BLKB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.11 per share, an increase this year of $0.16 per share, and an increase next year of $0.34 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

Blackbaud Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):